our approach aimed at maximizing productivity & efficiency.
modern ways of manufacturing products.
Aenean et tellus facilisis luctus magna et, ullamcorper velit. Suspendisse potenti. Nam non erat magna. Nunc ac fringilla neque. Suspendisse fermentum purus id ipsum aliquam, nec feugiat metus molestie. Fusce finibus sem volutpat hendrerit dolor eget.
En pellentesque magna nec libero suscipit aliquam. Vestibulum ante ipsum primis faucibus orci luctus et ultrices posuere cubilia curae; Fusce dui est, ultricies nec ultriciesa porttitor quis tellus. Sed tristique erat, ac rhoncus nisl. Mauris erat urna, egestas nec nibh ut, sagittis convallis lacun. Phasellus varius urna in scelerisque convallis. Aenean rhoncus non eros et viverra.
Industry 4.0 – the systematic approach
Nam gravida erat vel metus varius, imperdiet facilisis lorem pharetra. Vestibulum convalis porter duiy in congue felis eleifend eget. Aliquam nulla eros, ultrices sit amet tempus ac, elementum at ipsum. Donec sollicitudin commodo tellus at rutrum.
predictive machines
Fusce dui est ultricies nec ultricies acd porttitor quis tellus ned.
certified factory
Fusce dui est ultricies nec ultricies acd porttitor quis tellus ned.
service related FAQ’s
Some key documents include the Technical Documentation (Annex II & III), Clinical Evaluation Report (CER), Risk Management File, PMS/PMCF Plans, and labeling/instructions for use (IFU) compliant with GSPR
Yes, we provide full support for UDI implementation and registration in compliance with EU MDR 2017/745 and IVDR 2017/746 requirements. Our team assists manufacturers in assigning and structuring UDI-DI and UDI-PI codes based on the device classification and intended use. We also help in ensuring proper placement of UDI on labeling, packaging, and Instructions for Use (IFU), as well as preparing for UDI module submission once it becomes fully functional within EUDAMED.
Our services cover:
-
UDI-DI and UDI-PI structure guidance
-
Compliance with GS1, HIBCC, or ICCBBA issuing agencies
-
UDI label and packaging review
-
Preparation for EUDAMED UDI/Device registration module
-
UDI-related documentation for your Technical File and CE submission
By integrating UDI properly, we help ensure device traceability, reduce market delays, and support full regulatory compliance across the EU.
Yes. If your company is based outside the EEA and wishes to market medical devices or IVDs in Europe, it is legally required to appoint an EC REP. This representative’s name and address must appear on the product labeling, outer packaging, or Instructions for Use (IFU).
The drug Master Files are divided into 4 Types
Type I: Manufacturing Site, Facilities, Operating Procedures, and Personnel
Type II: Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
Type III: Packaging Material
Type IV: Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
Type V: FDA Accepted Reference Information
We provide US Agent service and E copy submission service. We also help with DMF preparation.
Form MD-22: This is the application form submitted to the Central Licensing Authority (CLA) (i.e., DCGI under CDSCO) to seek permission for conducting a clinical investigation of a new medical device or an investigational medical device without a predicate device in India.
Form MD-23: If the CLA is satisfied with the application, it grants permission to conduct the clinical investigation through Form MD-23. This permission allows the sponsor to begin the study in accordance with an approved clinical investigation plan reviewed by a registered Ethics Committee.
Additional requirements:
-
The clinical investigation must be registered with the Clinical Trials Registry – India (CTRI) before the enrolment of the first participant.
-
The first participant must be enrolled within one year of the grant of permission; otherwise, fresh permission from the CLA is required.
